CNBC: Actavis swoops in on Allergan for Salix buyout talks

Talk about a love triangle. Actavis ($ACT) made an advance toward Allergan ($AGN) last month, which the latter spurned because it thought it was close to landing Salix ($SLXP). Now, sources tell CNBC that Actavis has swooped in on Salix, with deal talks ongoing. Report